Skip to main content
Nick Dimitrios Tsihlis, PhD

Nick Dimitrios Tsihlis, PhD

Research Professor of Surgery, Surgery

Primary Location
1240 Pinn Hall
1340 Jefferson Park Ave
Charlottesville, Virginia 22903
Primary Phone Number

Bio & Overview

Our lab uses nanoscale materials to target a variety of diseases through IV injection, including: abdominal aortic aneurysm, arterial injury/hyperplasia, atherosclerosis, hemorrhage, and smoke-induced acute lung injury.

Academic Information

Department
Surgery

Primary Education

  • B.A., Biochemistry and Cell Biology, Rice Universitynull
  • Ph.D., Biochemistry, Louisiana State Universitynull

Research Interests

Vascular Biology, Nanotechnology, Biomaterials, Drug Delivery

Research Disciplines

  • Biochemistry
  • Biomedical Engineering
  • Cardiovascular Biology
  • Cell and Developmental Biology
  • Experimental Pathology
  • Materials Science
  • Molecular Biology
  • Molecular and Cellular Physiology
  • Physiology

Research Opportunities

  • Biochemistry
  • Cardiovascular Disease
  • Cell Biology
  • Experimental Pathology
  • Molecular Biology
  • Physiological Basis of Human Disease

PhD Programs

  • Physiology

Selected Publications

2026

Ascorbate elastomer-coated ePTFE grafts inhibit neointimal hyperplasia and enhance vascular healing
Bioactive Materials. 2026; 56: 726 - 742. DOI:10.1016/J.BIOACTMAT.2025.10.014.

Humanized Citrullinated Histone H3 Monoclonal Antibody Improves Respiratory Function and Attenuates Neutrophil-Mediated Inflammation in a Rodent Model of Smoke Inhalation Lung Injury
Journal of the American College of Surgeons. 2026; 242(1): 1 - 12. DOI:10.1097/XCS.0000000000001620.

Mitsugumin 53 protects against smoke inhalation lung injury via suppressing the proinflammatory response in a rat model
Free Radical Biology and Medicine. 2026; 248: 43 - 51. DOI:10.1016/J.FREERADBIOMED.2026.02.027.

Nitric Oxide-releasing Nanofibers Prevent Restenosis After Arterial Injury in a Renal Failure Model
Journal of Surgical Research. 2026; 325: 746 - 756. DOI:10.1016/J.JSS.2026.03.115.

Peptide amphiphile nanofibers: advanced drug delivery platforms for cardiovascular therapeutics
Expert Opinion on Drug Delivery. 2026; 23(5): 909 - 917. DOI:10.1080/17425247.2026.2631770.

2025

Apolipoprotein E Deficiency Produces an Inflammatory Abdominal Aortic Aneurysm in a Rat Calcium Chloride-Induced Model
Journal of Surgical Research. 2025; 312: 83 - 93. DOI:10.1016/J.JSS.2025.05.011.

2023

A Targeted Nanofiber Loaded With Liver X Receptor Agonist Reduces Atherosclerotic Plaque and Prevents Hepatotoxicity
JVS: Vascular Science. 2023; 4: 100152. DOI:10.1016/J.JVSSCI.2023.100152.

Abstract 127: A Targeted Nanofiber Loaded With Liver X Receptor Agonist Reduces Atherosclerotic Plaque And Prevents Hepatotoxicity
Arteriosclerosis, Thrombosis, and Vascular Biology. 2023; 43(Suppl_1):. DOI:10.1161/ATVB.43.SUPPL_1.127.

Effects of Particle Size, Charge, Shape, Animal Disease State, and Sex on the Biodistribution of Intravenously Administered Nanoparticles
Particle and Particle Systems Characterization. 2023; 40(7):. DOI:10.1002/PPSC.202300001.

Systemic peptide amphiphile nanofiber delivery following subcutaneous injection
Biomaterials. 2023; 303: 122401. DOI:10.1016/J.BIOMATERIALS.2023.122401.

2022

Peptide Amphiphile Supramolecular Nanofibers Designed to Target Abdominal Aortic Aneurysms
ACS Nano. 2022; 16(5): 7309 - 7322. DOI:10.1021/ACSNANO.1C06258.

2021

Coating small-diameter ePTFE vascular grafts with tunable poly(diol- co -citrate- co -ascorbate) elastomers to reduce neointimal hyperplasia
Biomaterials Science. 2021; 9(15): 5160 - 5174. DOI:10.1039/D1BM00101A.

Development of Novel Nanofibers Targeted to Smoke-Injured Lungs
Biomaterials. 2021; 274: 120862. DOI:10.1016/J.BIOMATERIALS.2021.120862.

Emerging antenatal therapies for congenital diaphragmatic hernia-induced pulmonary hypertension in preclinical models
Pediatric Research. 2021; 89(7): 1641 - 1649. DOI:10.1038/S41390-020-01191-X.

Evaluation of a Targeted Drug‐Eluting Intravascular Nanotherapy to Prevent Neointimal Hyperplasia in an Atherosclerotic Rat Model
Advanced NanoBiomed Research. 2021; 1(7):. DOI:10.1002/ANBR.202000093.

Intravenous Delivery of Lung‐Targeted Nanofibers for Pulmonary Hypertension in Mice
Advanced Healthcare Materials. 2021; 10(13):. DOI:10.1002/ADHM.202100302.

Self‐Assembled Peptide Amphiphile Nanofibers for Controlled Therapeutic Delivery to the Atherosclerotic Niche
Advanced Therapeutics. 2021; 4(9):. DOI:10.1002/ADTP.202100103.

Targeted Delivery of a Nanotherapeutic to Prevent Arterial Restenosis in a Diabetic Environment
Journal of the American College of Surgeons. 2021; 233(5): S316 - S317. DOI:10.1016/J.JAMCOLLSURG.2021.07.656.

2020

A comparative study of a preclinical survival model of smoke inhalation injury in mice and rats
American Journal of Physiology - Lung Cellular and Molecular Physiology. 2020; 319(3): L471 - L480. DOI:10.1152/AJPLUNG.00241.2020.

Development of Fractalkine-Targeted Nanofibers that Localize to Sites of Arterial Injury
Nanomaterials. 2020; 10(3): 420. DOI:10.3390/NANO10030420.

Development of Optimized Tissue-Factor-Targeted Peptide Amphiphile Nanofibers to Slow Noncompressible Torso Hemorrhage
ACS Nano. 2020; 14(6): 6649 - 6662. DOI:10.1021/ACSNANO.9B09243.

Development of Poly(1,8-octanediol- co -citrate- co -ascorbate) Elastomers with Enhanced Ascorbate Performance for Use as a Graft Coating to Prevent Neointimal Hyperplasia
ACS Applied Bio Materials. 2020; 3(4): 2150 - 2159. DOI:10.1021/ACSABM.0C00019.

Emerging Therapies for Prehospital Control of Hemorrhage
Journal of Surgical Research. 2020; 248: 182 - 190. DOI:10.1016/J.JSS.2019.09.070.

Emerging therapies for smoke inhalation injury: a review
Journal of Translational Medicine. 2020; 18(1):. DOI:10.1186/S12967-020-02300-4.

Pharmacokinetics and biodistribution of a collagen‐targeted peptide amphiphile for cardiovascular applications
Pharmacology Research & Perspectives. 2020; 8(6):. DOI:10.1002/PRP2.672.

2019

Atheroma Niche‐Responsive Nanocarriers for Immunotherapeutic Delivery
Advanced Healthcare Materials. 2019; 8(3):. DOI:10.1002/ADHM.201801545.

Peptide Amphiphile Supramolecular Nanostructures as a Targeted Therapy for Atherosclerosis
Macromolecular Bioscience. 2019; 19(6):. DOI:10.1002/MABI.201900066.

Peptide Amphiphile Supramolecular Nanostructures as a Targeted Therapy for Atherosclerosis
Macromolecular Bioscience. 2019; 19(6):. DOI:10.1002/MABI.201970016.

2018

Correctionto Tissue-Factor Targeted Peptide Amphiphile Nanofibers as an InjectableTherapy To Control Hemorrhage
ACS Nano. 2018; 12(11): 11711 - 11711. DOI:10.1021/ACSNANO.8B07028.

Systemic Delivery of a Novel Fractalkine Binding Peptide Amphiphile Nanofiber to Target Injured Vasculature
Journal of the American College of Surgeons. 2018; 227(4): S296 - S297. DOI:10.1016/J.JAMCOLLSURG.2018.07.615.

2016

Nitric oxide differentially affects proteasome activator 28 after arterial injury in type 1 and type 2 diabetic rats
Journal of Surgical Research. 2016; 202(2): 413 - 421. DOI:10.1016/J.JSS.2016.01.030.

Tissue-Factor Targeted Peptide Amphiphile Nanofibers as an Injectable Therapy To Control Hemorrhage
ACS Nano. 2016; 10(1): 899 - 909. DOI:10.1021/ACSNANO.5B06025.